antibody, designated S-7B8, recognizes a protein antigen localized to highly selected populations of nerve terminals in spinal cord and brain. The antibody produces dense immunocytochemical staining of primary afferent endings that synapse in superficial laminae of the spinal cord dorsal horn. Electron microscopy shows staining to be localized in nerve terminals where reaction product is associated primarily with spherical vesicles. In brain, S-788 immunoreactivity occurs in nerve terminals in sensory relay nuclei, most thalamic nuclei, and other selected areas, including the cerebellar molecular layer, the substantia nigra, the globus pallidus, and certain synaptic layers of the hippocampus and dentate gyrus. Endocrine glands and other tissues do not exhibit S-7B8 immunoreactivity.
Although the antibody localizes to certain populations of nerve terminals that may use excitatory amino acid neurotransmitters, the distribution of S-7B8 immunoreactivity in the CNS does not correspond to that of any previously identified nerve terminal protein.
Experiments to characterize the S-7B8 antigen indicate it may be an integral membrane component since extraction of synaptosomes with alkaline pH or high ionic strength does not release the antigen from the membranes.
To identify the molecular weight of the S-7B8 antigen, synaptosomal membranes were solubilized in CHAPS and sequentially chromatographed on hydroxylapatite and then on DEAE anion-exchange resin to produce enriched fractions. When enriched fractions were separated on SDS-PAGE and Western blotted, the S-7B8 antibody specifically stained a protein migrating at 75,000 Da. This protein has been designated NT78 Preliminary studies of developing pathways show that the appearance of S-7B8 immunoreactivity in growing nerve endings corresponds closely to the time when synaptic connections are formed. Thus, the NT75 protein recognized by the S-7B8 antibody may have a role in the development and maintenance of specific synaptic endings.
Nerve terminals contain the specialized organelles and constituent proteins involved in the secretion of neurotransmitters and in the maintenance of the presynaptic membrane and synaptic contact. In this respect the protein composition of nerve terminals differs substantially from that of the rest of the cell, although it is generally accepted that proteins destined for nerve terminals are axonally transported from their site of synthesis in the nerve cell body. As far as the protein composition of nerve terminals is known, it appears that the great majority of these proteins are common to all nerve terminals. Proteins involved in various aspects of the secretory process, including routing of synaptic vesicles, docking and fusion of vesicles with the plasma membrane, and vesicle retrieval and recycling, seem likely to be shared by most neurons (see Kelly and Hooper, 1982; Kelly et al., 1983; Smith and Augustine, 1988) . Several of the constituent proteins of synaptic vesicle membranes have been recently identified (Matthew et al., 1981; Huttner et al., 1983; Buckley and Kelly, 1985; Jahn et al., 1985; Wiedenmann and Franke, 1985) . They have widespread distributions in central and peripheral nerve terminals, and, in certain instances, are components of secretory vesicles of non-neuronal cells. In contrast to nerve terminal proteins that have widespread distributions, a small number of identified proteins are limited to selected populations of nerve endings. Perhaps the best characterized are those associated with specific neurotransmitters. These include dopamine-P-hydroxylase in noradrenergic nerve terminals (Axelrod and Kopin, 1969; Swanson and Hartman, 1975) , choline acetyltransferase in cholinergic nerve terminals (Wainer et al., 1984) , and the secretogranins in peptidergic nerve endings (Kennedy, 1985; Rosa et al., 1985) . Furthermore, components of various second-messenger systems, which mediate effects on neurotransmitter release through protein phosphorylation, are known constituents of nerve terminals and have been found to be selectively distributed (Ouimet et al., 1984; Miller, 1985; Worley et al., 1986a, b) .
Selectively distributed nerve terminal proteins have also been implicated in various aspects of axonal growth, guidance, recognition, and cell-to-cell adhesion (Sperry, 1963; Thiery et al., 1977; Sanes et al., 1978; Gottlieb and Glaser, 1980; Schachner et al., 1983; Dodd et al., 1984; Schwab and Gottlieb, 1988) . Examples of this class include the growth-associated proteins, or GAPS (for review, see Benowitz and Routtenberg, 1987) , proteins associated with nerve growth cones (Ellis et al., 1985; Wallis et al., 1985) , and recently described proteins associated with electromotor nerve terminals, including agrin (Magill-Sole and McMahan, 1988 ) and the nerve terminal anchorage protein, TAP-l (Carlson et al., 1986) .
This report describes studies that have led to the identification of a nerve terminal protein with a restricted and unique distribution in spinal cord and brain. A monoclonal antibody, designated S-7B8, was developed using brain synaptosomes as immunogen. This antibody localizes to selected populations of nerve terminals where immunocytochemical staining is mainly associated with synaptic vesicles. Experiments to characterize the S-7B8 antigen indicate that it is a membrane protein with a molecular weight of approximately 75,000 Da. Preliminary studies in developing nervous system suggest that this antigen may have a role in the formation and maintenance of specific populations of synaptic endings. Portions of this work have been reported previously in abstract form Ritchic et al., 1986b, c; Wright et al., 1986) . perfused and immunocytochemical staining was carried out as described.
Electron microscopy. The staining in the spinal cord produced by the S-7B8 antibody was localized at the ultrastructural level by preembedding immunocytochemistry with the PAP method (Pickel et al., 1975; Ruda et al., 1982) . The fixative solution was 4.0% paraformaldehyde and 0.05-0.1% glutaraldehyde in 50 mM phosphate buffer, pH 7.4. Immunocytochemical staining of 50 pm vibratome sections was similar to that employed for light microscopy with the exception that detergents were omitted from all solutions. Following immunocytochemical staining, sections were postfixed in buffered 2.0% glutaraldehyde for 30-60 min, then in 1 .O% osmium tetroxide for 1 hr, dehydrated with ethanol, and embedded in Spurr's resin. Thin sections (loo-120 nm) were prepared from the surface of the vibratome sections and were viewed and, photographed without counterstaining in a Hitachi H-600 electron microscope.
Materials and Methods Materials
Hydroxylapatite (Bio-Gel HT) was purchased from Bio-Rad and DEAE Sepharose CL-6B from Pharmacia. 3-[(3-cholamidopropyl)dimethylammoniol-1 -propansulfonate (CHAPS) and ultrapure T& were obtained from Boehrinaer Mannheim. Trvpsin (Tvpe XIII) and sovbean trypsin inhibitor (Type I-S) were purchased f&&Sigma. Nitrocelhtlose paper was purchased from Millipore (0.45 pm) or Schleicher and Schuell (0.2 pm; BA83). Acrylamide, electrophoresis grade, was obtained from Eastman Kodak Company, and other electrophoresis reagents and standards were purchased from Bio-Rad. Immunochemical reagents were obtained from Cooper Biomedical (goat anti-mouse IgG, with no crossreactivity to rat IgG; peroxidase-conjugated goat anti-mouse IgG), Sternberger-Meyer (mouse peroxidase-antiperoxidase), or Jackson Immunochemicals (purified nonimmune mouse IgG).
Neuronal membrane preparations
Quantitative analysis of the S-7B8 antigen in various subcellular and protein fractions from rat brain was carried out using a dot-immunobinding assay. Initially, the protocol supplied with the Bio-Dot apparatus was followed (Bio-Rad). In later experiments, the procedure was modified to facilitate the binding of proteins in detergent solution to the nitrocellulose paper. Samples were diluted in PBS and 0.5-5 pg protein was applied to each well. On each assay, synaptosome standards were spotted at 0.1-10 &well. For detergent-containing samples, proteins were precipitated onto the nitrocellulose paper with 50 pl of 20% trichloroacetic acid (TCA) for 1 min; the solution was then drawn through the membrane and rinsed once with PBS. The membrane was then removed from the apparatus and dried. One set of samples was stained for total protein with aniline blue/black, while a duplicate set for staining with antibodies was incubated with 5% nonfat drv milk in PBS (BLOT-TO) (Johnson et al., 1984) . Immunostaining was accomplished using an indirect peroxidase method with antibodies diluted in BLOTTO, and the peroxidase reaction was carried out as described nreviouslv (Ritchie et al., 1986a) . The assays were analyzed with a scanning densitometer and the specific activity (antigen units/pg protein) of experi-
Dot immunobinding assay
Synaptosomes were prepared from whole rat brain by a modification mental fractions was determined by comparison with the synaptosome of the method of Gurd et al. (1974) , as described previously (Ritchie et standards. By definition, 1.0 antigen unit corresponds to the S-7B8 al., 1985) . Rat brain particulate fractions were prepared by centrifuimmunoreactivity in 1 .O pg of brain synaptosomes on the assay system. gation (160,000 x g x 2 hr) of the postnuclear supernatant. Membrane
The S-7B8 specific activity of synaptosomes is thus 1.0 (1.0 antigen pellets were lyophilized and stored at -70°C. unit/pg protein).
Monoclonal antibodies
Monoclonal antibodies to rat brain synaptosomes were prepared by conventional somatic cell hybridization methods (Kennett et al., 1978) . Details of the immunization, and the monoclonal antibody production and screening methods have been described previously (Ritchie et al., 1986a) . Twenty-one clones were selected, expanded, and subcloned by limiting dilution. This report presents studies using the antibody (IgG, subclass) secreted by the S-7B8 cell line. A monoclonal antibody to synaptophysin (SY 38), a M, 38,000 synaptic vesicle protein (Wiedenmann and Franke, 1985) was purchased from Boehringer Mannheim Biochemicals.
Immunocytochemistry
Light microscopy. Rats were deeply anesthetized and perfused with saline followed by freshly prepared 3.5-4.0% paraformaldehyde in 50 mM phosphate buffer, pH 7.4. Frozen sections (20-40 Km) of spinal cord, brain, and other tissues were stained with S-7B8 antibody from ascitic fluid (diluted l/1000-l/20,000) or culture supernatant (diluted l/1-1/10) using the peroxidase-antiperoxidase (PAP) method of Sternberger (1978) . Details of the immunocytochemical staining procedure have been described elsewhere (Ritchie et al.. 1985 (Ritchie et al.. , 1986a . Controls consisted of omitting S-7B8 antibody from the overnight incubation solution or usine ascitic fluid from the narent mveloma cell line or purified nonimmmre mouse IgG as prima& antibodies. No staining was observed on control sections.
To determine the origins of stained terminals in the superficial dorsal horn of the spinal cord, unilateral dorsal rhizotomies were performed (4 animals). Three to 6 consecutive lumbosacral dorsal roots were sectioned, and survival times of 6-l 4 d were used. In a second group of 4 animals, gel foam pads soaked in colchicine (20 mg/ml) were applied to lumbar dorsal root ganglia L4-L6. After 16-48 hr, the animals were Chromatography on hydroxylapatite An "alkaline-stripped" neuronal membrane preparation was used as starting material for column chromatography. "Alkaline-stripped" membranes were prepared by homogenizing lyophilized synaptosomes or brain particulate fraction in 20 mM Tris, pH 10.5, and centrifuging at 160,000 x g x 2 hr. The resulting membrane pellet was then lyophilized and stored at -70°C until used. For chromatography, alkalinestripped membranes were homogenized in 75 mM sodium phosphate buffer, pH 7.2 (PB), containing 16 mM CHAPS and protease inhibitors (10 pg/ml aprotinin, 1 pg/ml leupeptin, 2 fig/ml antipain, 10 &ml benzamidine, 1 &ml chymostatin, and 1 fig/ml pepstatin A; Lopez et al., 1985) . The CHAPS soluble fraction (supematant) was obtained after centrifugation at 160,000 x g for 2 hr and applied to a hydroxylapatite column (1.5 x 12 cm) equilibrated in 75 mM PB and 16 mM CHAPS. The column was washed with equilibration buffer and then bound proteins were eluted with a 110 ml linear gradient of 75-200 mM sodium phosphate, pH 7.2, containing 16 mM CHAPS, at a flow rate of 8 ml/ hr, and 2 ml fractions were collected. Chromatography was carried out at 4°C. Gradient fractions containing the S-7B8 antigen were identified on the dot-immunobinding assay and pooled.
Chromatography on DEAE-Sepharose CL-6B
Pooled hydroxylapatite column fractions containing peak S-7B8 specific activity were applied directly to a 1 x 7 cm column of DEAE-Sepharose CL-6B (flow rate of 20 ml/hr) that was equilibrated in 20 mM Tris-HCl buffer, pH 8.0, containing 150 mM NaCl and 16 mM CHAPS (TBS/ CHAPS). The column was washed with TBSCHAPS and bound proteins were eluted with a 50 ml linear gradient of 150-450 mM NaCl in TBCHAPS at a flow rate of 5 ml/hr and 2 ml fractions were collected. Chromatography was carried out at 4°C. The S-7B8 specific activity of
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SDS-PAGE and immunoblotting
Protein samples were electrophoresed on 7.5% acrylamide minigels (BioRad Mini-Protean II apparatus) using the discontinuous buffer system of Laemmli (1970) . Proteins were electrophoretically transferred to 0.2 pm nitrocellulose paper, at 100 V for 70 min at 4"C, and stained with antibodies diluted in BLOTTO using an indirect immunoperoxidase method (Towbin et al., 1979 Figure 1A . Staining is present in the dorsal horn (laminae I-V) and is densest in the superficial part (laminae I and Hi). This staining consists of punctate granules, suggestive of a localization to nerve terminals (Fig. lA, right the spinal white matter is restricted to a small area in the dorsal part of the lateral funiculus.
To further illustrate the high degree of selectivity exhibited by the S-7B8 antibody, the staining pattern produced in the spinal cord by anti-synaptophysin is illustrated (Fig. 1B) . Anti-synaptophysin staining occurs throughout the spinal gray matter, and the staining appears highly punctate. The staining pattern is consistent with the localization of synaptophysin in synaptic vesicle membranes of virtually all nerve terminals (Jahn et al., 1985; Wiedenmann and Franke, 1985) .
Origin of stained nerve terminals. Since the S-7B8 antibody stains nerve terminals concentrated in the dorsal horn, further experiments evaluated whether dorsal root ganglion cells are the source of the labeled terminals. The S-7B8 antibody normally does not stain cell bodies in the dorsal root ganglia. However, application of colchicine to the ganglia to block axonal transport results in the staining of large numbers of small-and mediumsized ganglion cells, and some large-sized ganglion cells (Fig. 2B) . Consistent with these results, sectioning the dorsal roots produces a marked loss of staining in the superficial laminae (I, II) of the dorsal horn (Fig. 24 . Laminae III-V also show a depletion following dorsal rhizotomy, but residual staining is present. These results indicate that primary afferent neurons contribute most of the S-7B8-positive nerve terminals to laminae I and II, and a portion of those to laminae III-V of the spinal cord.
Brain. In the brain, the S-7B8 antibody produces punctate staining of selected populations of nerve terminals (Fig. 3) . Cell bodies and most fiber tracts are not stained. S-7B8 immunoreactivity is prominently associated with nerve terminals of sensory pathways, including the terminal fields of all the primary sensory systems and their respective brain-stem relay and thalamic nuclei. A number of other areas also exhibit dense staining, including the cerebellar molecular layer, substantia nigra, globus pallidus, various cerebral cortical areas, and certain synaptic layers of the hippocampus and dentate gyrus (Goodlett et al., 1986; Wright et al., 1986) .
Endocrine glands and other tissues. Immunocytochemical staining with the S-7B8 antibody is virtually absent in adrenal gland, thyroid, pituitary, and pancreas (not illustrated). Some sparse punctate staining, which gives the appearance of labeled nerve terminals, occurs in the neural lobe of the pituitary. S-7B8 immunoreactivity is not observed in non-neuronal cells, including liver, glabrous skin, skeletal muscle, or proximal and distal small intestine.
Electron microscopy. As suggested by the light microscopic Figure 3 . A, Immunocytochemical staining of rat brain with S-7B8 antibody produces dense labeling of nerve terminals in selected brain regions including: A and B, spinal trigeminal nucleus; C, molecular layer of the cerebellum, D, inferior colliculus; E, superior colliculus (superficial laminae), medial geniculate, and dorsal lateral geniculate nuclei, and substantia nigra; and F, the ventrobasal thalamus and portions of the cerebral cortex. The hippocampus exhibits a striking laminar pattern of staining.
examination of spinal cord sections stained with S-7B8 antibody, electron microscopic analysis reveals numerous labeled profiles in laminae I and II of the spinal cord dorsal horn. These are scattered among many unlabeled profiles. The S-7B8-positive structures are nerve terminals of varying size, and the reaction product appears to be primarily associated with 40-50 nm spherical vesicles in the labeled terminals (Fig. 4) . In some cases, the reaction product is also associated with the inner surface of the nerve terminal plasma membrane, or with mitochondrial membranes (Fig. 4A) . The larger terminals exhibiting S-7B8 immunoreactivity (Fig. 4A) appear to correspond to the central terminals of primary afferents described previously by others (Ralston, 1979; Riberio-da-Silva and Coimbra, 1982) . Stained terminals are often observed in close apposition to or making synaptic contact with unstained dendritic processes (Fig.   4 , A-C).
Within lamina II, staining with the S-7B8 antibody is also observed in some small-sized (0.2 Mm), round vesicle-containing structures which occur in bundles outside of synaptic zones (Fig.  40) . These structures may correspond to "axon fields" described previously in lamina II, which are comprised of bundles of unmyelinated axons (Ralston, 1968 (Ralston, , 1979 ; Riberio-da-Silva and After incubation for 2 hr at 4°C the samples were centrifuged at 115,000 x g for 2 hr. The protein content of the pellets and supernatants was assayed (Bradford, 1976) , and the S-7B8 antigen was analyzed on the dot-immunobinding assay. Values averaged from 2 experiments were plotted.
Coimbra, 1982). These "axon fields" contained both labeled and unlabeled profiles. In a few instances, staining is also ob-
Profiles not observed to stain with the S-7B8 antibody include neuronal cell bodies, flattened vesicle-containing terminals, denserved within small-caliber myelinated axons. drites, and glial elements.
Antigen characterization
To characterize the antigen recognized by the S-7B8 antibody, initial studies involved repeated extraction of synaptosomes with chloroform/methanol. This treatment, which should solubilize membrane lipids and proteolipids (Gombos and Zanetta, 1977) , does not extract the S-7B8 antigen, which remains in the insoluble pellet. Next, the effect of a proteolytic enzyme was evaluated. Digestion of synaptosomes with trypsin diminishes the specific activity of the S-7B8 antigen, with losses approaching 90%, at a trypsin to synaptosomal protein ratio of 1:2. Synaptosomes treated with trypsin plus a specific trypsin inhibitor Lyophilized synaptosomes were homogenized in 10 mM Tris buffer, pH 7.5. Aliquots of the suspension were adjusted to pH 8.5-9, 10.5-10.8, or 11.9-l 2.0 by the addition of NaOH and centrifuged at 115,000 x g for 2 hr. The resuspended pellets and the supematants were adjusted to pH 7.5 prior to analysis of protein content (Bradford, 1976) and S-7B8 antigen on the dot-immunobinding assay. Average values from 3 experiments are graphed. Note that at pH 12.0 S-7B8 antigen cannot be detected in either the pellet (retained fraction) or the supematant (released fraction).
retain up to 80% of the S-7B8 specific activity, at a ratio of trypsin to trypsin inhibitor of 1:2 to 1:3. These results suggest that the S-7B8 antigen is a protein.
The S-7B8 antigen is not readily solubilized from synaptosomal membranes and is thus likely to be an integral membrane component. Greater than 90% of the S-7B8 antigen is retained in the insoluble pellets after extraction of synaptosomes with 1 .O M NaCl or with KC1 at concentrations ranging from 0.1 to 1.0 M, at pH 7.5 or 8.5 (Fig. 5) . Similarly, extraction of synaptosomes with buffers up to pH 10.5 does not release the S-7B8 antigen from the membranes, although greater than 50% of the total synaptosomal protein is released at this pH (Fig. 6) . It was not possible to determine whether higher pH releases the S-7B8 antigen since exposure of synaptosomes to pH above 11 .O abolishes S-7B8 immunoreactivity in the fractions. Although high ionic strength or high pH do not solubilize the S-7B8 antigen from synaptosomal membranes, several nonionic and zwitterionic detergents (0.5-l .O% Triton X-100, 35-40 mM n-octyl-glucoside, 8-l 6 mM CHAPS) were found to be effective solubilization agents (see below). Initial efforts to identify the molecular weight of the S-7B8 antigen using SDS-PAGE and Western blotting of synaptosomal proteins were unsuccessful. No detectable S-7B8 activity was present among the blotted proteins. Analysis on the dot-immunobinding assay indicated that exposure of synaptosomes to SDS-PAGE sample buffer (containing 2% SDS, with or without 5% 2-mercaptoethanol) markedly reduces the S-7B8 activity. Various methods to renature proteins during the electrophoresis and blotting procedure (e.g., Mandrel1 and Zollinger, 1984) or the use of nondenaturing gel systems also proved unsatisfactory. Therefore, experiments were undertaken to partially purify the S-7B8 antigen using column chromatography.
In order to obtain samples enriched in S-7B8 antigen, detergent-solubilized neuronal membrane proteins were fractionated by chromatography on hydroxylapatite, and then on DEAE. The methods were first developed using a crude particulate fraction from rat brain as starting material because the yield of total protein in this fraction was much greater than that of purified synaptosomes. The high-speed centrifugation used to prepare the particulate fraction (160,000 x g) is sufficient to pellet synaptic vesicles released during the homogenization (Jahn et al., 1985) and this preparation has good activity for the S-7B8 antibody and for anti-synaptophysin. The experiments were then repeated using synaptosomes. The characteristics of binding to and elution from the 2 columns, as well as the apparent molecular weight of the S-7B8 antigen obtained from the 2 membrane preparations were essentially identical.
As described in Materials and Methods, rat brain synaptosomes or particulate fraction were first washed with alkaline pH buffer to produce an "alkaline-stripped" membrane preparation (see Fig. 6 ). The "alkaline-stripped" membrane pellet was then homogenized in CHAPS, and the soluble fraction was recovered after centrifugation. CHAPS (16 mM) was typically found to solubilize 65% of the total protein and 95% of the S-7B8 antigen in the "alkaline-stripped" membrane fractions. The CHAPSsolubilized proteins were then chromatographed on hydroxyl- apatite. Approximately 40-50% of the total protein applied to the hydroxylapatite column appears in the unbound fraction under the conditions utilized. Bound proteins, including the S-7B8 antigen, were eluted from the column with a gradient of 75-175 mM sodium phosphate, and the gradient fractions were analyzed for S-7B8 antigen on the dot-immunobinding assay. Fractions enriched in the S-7B8 antigen elute from the hydroxylapatite column between 125 and 175 mM PB (fractions 37-59) and exhibit apparent specific activity about 2.5 times that of synaptosomes (Table 1) .
To determine the S-7B8 specific activity in the column fractions, TCA precipitation was used to facilitate binding of the proteins to nitrocellulose paper in the presence of 16 mM CHAPS. This allowed rapid analysis of the S-7B8 activity in the fractions without removal of the detergent, which inhibits binding of proteins to nitrocellulose. It should be noted that even brief exposure of the proteins to TCA diminished the S-7B8 activity. However, the assay was sufficient to identify fractions enriched in the S-7B8 antigen, although the S-7B8 specific activity is underestimated (see Table 1 ).
The hydroxylapatite gradient fractions enriched in the S-7B8 antigen were pooled and applied directly to a DEAE-Sepharose CL-6B column. The S-7B8 antigen binds to the anion-exchange resin under the conditions used, whereas approximately 50% of the applied protein appears in the unbound fraction. The S-7B8 antigen elutes from the column between 275 and 325 mM NaCl, with peak specific activity about 100 times that of synaptosomes concentrated in 3 gradient fractions (fractions 12-l 4). Figure 7 illustrates the elution of total bound protein and the S-7B8 antigen from the anion-exchange column with the salt gradient. Table 1 shows the enrichment in the S-7B8-specific activity achieved at each step in the purification scheme.
The enriched fractions obtained after sequential chromatography over the 2 columns were then separated on SDS-PAGE and blotted to nitrocellulose. As illustrated in Figures 8 and 9 , the S-7B8 antibody stains a band migrating with an M, of approximately 75,000 Da, under both reducing and nonreducing conditions. This protein has been designated NT75. Including a b C a I I b Figure 8 . Identification of the S-7B8 antigen on immunoblots of enriched fractions generated by sequential chromatography of synaptosomal proteins on hydroxylapatite and DEAE-Sepharose. Lyophilized fractions were raised in sample buffer (2% SDS, 10% glycerol, and 0.67 M TrisHCl), without reducing agent, heated at 40°C for 10 min, then subjected to SDS PAGE on 7.5% minigels and blotted to nitrocellulose. Lanes correspond to enriched gradient fractions obtained from the DEAE column as follows: a and a', pooled fractions 10 and 11; b, b', and d, pooled fractions 12 and 13; c and c', pooled fractions 14 and 15. Nitrocellulose blots in lanes u-c were stained with the S-7B8 antibody, and in lane d with purified nonimmune mouse IgG. Lanes a'-~' are the corresponding SDS-PAGE gels stained for protein with Coomassie blue. Lanes a'-~' were loaded with approximately twice the amount of protein (60 pg) as were the lanes blotted and stained with antibodies (30 pg). Small arrowheads indicate the position of the molecular-mass standards: myosin (200,000), fi-galactosidase (116,250), phosphorylase B (97,400), BSA (66, 200) , and ovalbumin (42,699). Large urrows point to the position of the S-7B8 antigen, a protein of M, 75,000.
reducing agent (5% 2-mercaptoethanol) in the electrophoresis sample buffer markedly diminishes S-7B8 immunoreactivity, but it does not alter the M, of the stained band (Fig. 9) . Two additional bands exhibit light staining when the fractions having highest S-7B8 activity are electrophoresed under nonreducing conditions, the optimal conditions for demonstrating S-7B8 staining on immunoblots. These proteins, with apparent M, of 62,000 and 58,000 Da, may be proteolytic cleavage products of the 75,000 Da protein.
On Coomassie blue-or silver-stained SDS-PAGE gels of the same enriched fractions (Fig. 8, lanes a'-c') there is little detectable protein in the 75,000 Da region, even when the gel lanes are loaded with excess protein. Densitometric scans indicate that the protein in the 70,000-80,000 Da area of the Coomassiestained gels accounts for no more than l-2% of the total protein. Thus, the NT75 protein is a minor component of these fractions despite at least loo-fold enrichment in S-7B8 specific activity over the starting material (synaptosomes).
Discussion
The S-7B8 monoclonal antibody has been shown by immunocytochemistry to localize selectively to nerve terminals of restricted populations of neurons in the spinal cord and brain. This antibody was generated using rat brain synaptosomes as immunogen, in an attempt to identify molecules associated with specific populations of presynaptic terminals. Of 2 1 monoclonal antibodies evaluated by immunocytochemistry, the majority appeared to stain virtually all nerve terminals (Ritchie et al., 1986a) . The S-7B8 antibody was chosen for further study because it exhibits the highest degree of selectivity for certain presynaptic endings. Subsequently, the antibody has been used in immunochemical studies to identify and partially purify its antigen, a 75,000 Da protein. This protein has been designated NT75.
NT75 was identified as the S-7B8 antigen on immunoblots of enriched fractions generated by sequential column chroma- Figure 9 . Immunoblots of the S-7B8 antigen after SDS-PAGE under reducing and nonreducing conditions. Enriched fractions produced from a rat brain particulate fraction by doublecolumn chromatography as described were applied to the gels as follows: lane a, sample solubilized in buffer containing 2% SDS, 10% glycerol, and 0.067 M Tris-HCl, pH 6.8, and heated at 40°C for 10 mm; lane b, sample solubihzed in buffer as in a, but also containing 5% 2-mercaptoethanol, and heated at 40°C for 10 min; and lane c, sample solubilized in buffer as in b, and boiled for 3 min. All samples were electrophoresed on 7.5% minigels, transferred to nitrocellulose. and stained with the S-7B8 > antibody. Large arrows indicate the position of the S-7B8 antigen, NT75. Molecular-mass standards are the same as those in Figure 8 . The addition of reducing agent and boiling of the samples results in diminished S-7B8 activity on the blots, but all detectable activity remains at a position of 75,000 Da. a tography of synaptosomal membrane proteins. Two additional lower-molecular-weight bands, with M, of 62,000 and 58,000 Da, were lightly stained on the immunoblots. That these bands may be proteolytic fragments of the 75,000 Da protein is suggested by the observation that the ratio of these proteins to the 75,000 Da band is variable between experiments. Alternatively, the lower molecular-weight proteins may be distinct polypeptides that copurify with NT75 and contain the S-7B8 epitope. When electrophoresis is carried out under reducing conditions, staining of the 75,000 Da band is markedly reduced, and no other stained bands are evident. The effect of the reducing agent suggests that breaking disulfide bonds disrupts the S-7B8 epitope. In this context, a number of treatments known to denature proteins, including exposure to high pH, SDS, and boiling, diminish or abolish binding activity of the S-7B8 antibody, indicating that the epitope is dependent on the folded structure of the NT75 protein.
The localization of the NT75 protein to nerve terminals was indicated by immunocytochemical staining with the S-7B8 antibody. Cell bodies of neurons known to contain NT75 in their endings do not exhibit detectable staining, unless colchicine is applied to block axonal transport. The lack of staining in cell bodies most likely reflects a low concentration of NT75 in this compartment and suggests that NT75 is routed directly and b C exclusively for axonal transport to the nerve terminals. Thus, NT75 appears similar to other nerve terminal membrane proteins that are routed for fast anterograde axonal transport (Baitinger et al., 1982) .
The most striking feature of immunocytochemical localization of the NT75 protein is its selective association with subpopulations of nerve terminals. While the precise identification of all neuronal populations containing the NT75 protein is incomplete, it appears that many neurons comprising the sensory systems of the brain and spinal cord contain the NT75 protein. However, the S-7B8 antibody also localizes to nerve terminals in the substantia nigra, hippocampus, cerebellar cortex, and other CNS structures which are not generally considered components of "sensory" systems. Based upon the immunocytochemical staining pattern, it is not obvious what attribute or function might be shared by neurons containing the NT75 protein. It is of interest, however, that an essentially similar pattern of immunocytochemical staining reported here in the rat is also present in chicken and monkey (unpublished observations). This suggests that the NT75 protein, as well as its pattern of selective distribution, is highly conserved in evolution.
The pattern of the distribution of NT75, as well as characteristics of the molecule, allow for comparisons with other known nerve terminal proteins. A major class of nerve terminal pro-teins with selective distributions are those related to the synthesis, storage, uptake, or metabolism of neurotransmitters. However, it appears unlikely that NT75 is related to the neurotransmitter specificity of the neurons in which it is found. In brain, the pattern of S-7B8 immunoreactivity does not correlate with the localization of any known neurotransmitter or neurotransmitter-related substance. Although the nerve terminals of many pathways that may use excitatory amino acids (glutamate/aspartate) appear to stain with the S-7B8 antibody, NT75 does not correspond in molecular weight or cellular distribution to any of the enzymes involved in amino acid metabolism (Graybiel and Ragsdale, 1983; Ottersen and Storm-Mathisen, 1984) . In the spinal cord, the S-7B8-positive terminals are mainly those of primary sensory neurons projecting to the superficial dorsal horn. The candidate transmitters of primary afferents include various neuropeptides, excitatory amino acids, nucleotides, and the monoamines serotonin and dopamine (see Hunt, 1983; Jesse11 and Dodd, 1986) . The S-7B8 immunocytochemical staining in the spinal dorsal horn does not match the pattern of any single subpopulation of afferent terminals containing these putative transmitter substances. This reinforces the view that those nerve terminals containing NT75 are heterogeneous with respect to transmitter phenotype.
Components of certain second-messenger and protein phosphorylation systems are known to be constituents of nerve terminals, and to be selectively distributed in different populations of nerve cells. Of the components that have been mapped in brain, the localization of protein kinase C, as revealed by phorbol ester binding, seems to correspond most closely to the distribution of NT75 (Worley et al., 1986a, b) . Also, the reported molecular weight of protein kinase C, 77-82 KDa (Kikkawa et al., 1982; Girard et al., 1985) , approximates that determined for NT75. However, NT75, in the neural systems examined so far, is concentrated in nerve terminals, whereas protein kinase C has a wider distribution, being associated with certain myelinated fiber tracts, and with dendrites, cell bodies, and cell nuclei of several neuronal populations (Girard et al., 1985 (Girard et al., , 1986 Worley et al., 1986a, b; Saito et al., 1988) . In addition, protein kinase C is found in organs and tissues that do not exhibit S-7B8 immunoreactivity (Kuo et al., 1980) . Although the distribution of each of the different subspecies of protein kinase C have not been fully studied (see Saito et al., 1988 ), it appears unlikely that NT75 corresponds to protein kinase C or to any other known component of the protein phosphorylation systems described to date.
The immunoelectron microscopy studies suggest that NT75 may be associated with synaptic vesicle membranes, and possibly the cytoplasmic face of the nerve terminal plasma membrane. This localization agrees with results indicating that NT75 may be an integral membrane component. However, this interpretation of the staining in immunoreactive nerve terminals will need to be confirmed with higher resolution techniques, since diffusion of the DAB reaction product can produce artifact. It was not possible to resolve whether S-7B8 immunoreactivity appears in the presynaptic junctional membrane or the synaptic cleft, as might be expected for a synaptic vesicle component. It should also be noted that immunocytochemistry with the monoclonal antibody localizes only the portion of the NT75 protein containing the epitope, and thus a portion of the molecule could be exposed in the vesicle lumen or on the extracellular surface of the nerve terminal plasma membrane.
Several proteins associated with synaptic vesicles have recently been identified. Synapsin I, a peripheral membrane phosphoprotein doublet of 80,000-86,000 Da, is bound to the cytoplasmic surface of virtually all small synaptic vesicles in brain (De Camilli et al., 1983a, b; Huttner et al., 1983) . Proteins of 65,000 Da (Matthew et al., 1981) and 38,000 Da (synaptophysin) (Jahn et al., 1985; Wiedenmann and Franke, 1985; Obata et al., 1986) have widespread distributions in both central and peripheral nervous system synaptic vesicles, and also occur in the secretory vesicles of endocrine cells (Lowe et al., 1988) . A synaptic vesicle glycoprotein described by Buckley and Kelly (1985) with an M, of 75,000-85,000 Da in mammalian brain, exhibits a similar widespread distribution in neuronal and other secretory vesicles. Last, 2 phosphoproteins, IIIa and IIIb, of 74,000 and 55,000 Da, have recently been shown to be associated with vesicles in neurons and cells of the adrenal medulla (Browning et al., 1987) . NT75 does not appear to correspond to any of these previously characterized synaptic vesicle proteins on the basis of its apparent molecular weight, localization in selected nerve terminals, and lack of occurrence in endocrine (or other non-neuronal) cells.
Other proteins associated with nerve terminals and growth cones have been implicated in axonal growth, regeneration, and the formation of synaptic connections. In this group are the growth-associated proteins, or GAPS (Skene and Willard, 198 1; Benowitz and Lewis, 1983; Meiri et al., 1986; Skene et al., 1986; Gorgels et al., 1987; Neve et al., 1987) . GAP-43 occurs in selected nerve terminals in adult nervous system, although it is best known for the highly elevated levels occurring in developing and regenerating axons and growth cones (Oestreicher and Gispen, 1986; Benowitz et al., 1988) . Analysis of S-7B8 immunoreactivity in developing nervous system has shown that NT75 appears in growing fibers and becomes concentrated in the nerve terminals during synaptogenesis Cabalka et al., 1987 Cabalka et al., , 1988 Wright et al., 1987) . Like GAP-43, NT75 has recently been shown to occur at elevated levels in developing spinal cord as compared with the adult (Cabalka et al., 1987) . Thus, NT75 shares certain characteristics with the class ofnerve terminal components thought to have roles in development and regeneration. However, it must be recognized that whatever role the NT75 protein may have in developing nerve terminals, this function is restricted to certain populations of neurons and is maintained, at least in part, in the adult nervous system.
